169 related articles for article (PubMed ID: 23796008)
21. The value of simultaneous co-registration of 99mTc- MDP and 131Iodine in metastatic differentiated thyroid carcinoma.
Kotb MH; Omar W; El-Maghraby T; El-Bedwihy M; El-Tawdy M; Mustafa H; Al-Nahhas A
Nucl Med Rev Cent East Eur; 2007; 10(2):98-105. PubMed ID: 18228214
[TBL] [Abstract][Full Text] [Related]
22. Clinical experience with recombinant human thyrotrophin (rhTSH) in the management of patients with differentiated thyroid cancer.
Mariani G; Ferdeghini M; Augeri C; Villa G; Taddei GZ; Scopinaro G; Boni G; Bodei L; Rabitti C; Molinari E; Bianchi R
Cancer Biother Radiopharm; 2000 Apr; 15(2):211-7. PubMed ID: 10803328
[TBL] [Abstract][Full Text] [Related]
23. [Patients treated for differentiated thyroid cancer with negative 131I whole-body scans and elevated thyroglobulin levels: a possible course].
Gutiérrez Cardo AL; Rodríguez Rodríguez JR; Borrego Dorado I; Navarro González E; Tirado Hospital JL; Vázquez Albertino R
Rev Esp Med Nucl; 2007; 26(3):138-45. PubMed ID: 17524307
[TBL] [Abstract][Full Text] [Related]
24. Double-phase (131)I whole body scan and (131)I SPECT-CT images in patients with differentiated thyroid cancer: their effectiveness for accurate identification.
Wakabayashi H; Nakajima K; Fukuoka M; Inaki A; Nakamura A; Kayano D; Kinuya S
Ann Nucl Med; 2011 Nov; 25(9):609-15. PubMed ID: 21725630
[TBL] [Abstract][Full Text] [Related]
25. Thymus uptake of 131I in patients with differentiated thyroid carcinoma: Three different case scenarios and patterns of uptake and the importance of its recognition in thyroid cancer practice.
Abhyankar A; Basu S
J Cancer Res Ther; 2015; 11(3):648. PubMed ID: 26458613
[TBL] [Abstract][Full Text] [Related]
26. Are there disadvantages in administering 131I ablation therapy in patients with differentiated thyroid carcinoma without a preablative diagnostic 131I whole-body scan?
Salvatori M; Perotti G; Rufini V; Maussier ML; Dottorini M
Clin Endocrinol (Oxf); 2004 Dec; 61(6):704-10. PubMed ID: 15579184
[TBL] [Abstract][Full Text] [Related]
27. Inflammatory diseases of the lung causing false-positive 131iodine whole body scans in the evaluation of papillary thyroid carcinoma. Two case reports.
Pina JS; Meyer CA; Billingsley JL; Matlock JP; Horan MP; Knodel DH
Chest; 1996 Aug; 110(2):565-7. PubMed ID: 8697869
[TBL] [Abstract][Full Text] [Related]
28. I-131 SPECT/CT elucidates cryptic findings on planar whole-body scans and can reduce needless therapy with I-131 in post-thyroidectomy thyroid cancer patients.
Blum M; Tiu S; Chu M; Goel S; Friedman K
Thyroid; 2011 Nov; 21(11):1235-47. PubMed ID: 22007920
[TBL] [Abstract][Full Text] [Related]
29. False-positive I-131 uptake at a tracheostomy site. Discernment with Tl-201 imaging.
Ain KB; Shih WJ
Clin Nucl Med; 1994 Jul; 19(7):619-21. PubMed ID: 7924106
[TBL] [Abstract][Full Text] [Related]
30. Normal gallbladder visualization during post-ablative iodine-131 scan of thyroid cancer.
Seok JW; Kim SJ; Kim IJ; Kim YS; Kim YK
J Korean Med Sci; 2005 Jun; 20(3):521-3. PubMed ID: 15953883
[TBL] [Abstract][Full Text] [Related]
31. Littoral cell angioma presenting as metastatic thyroid carcinoma to the spleen.
Mohan V; Jones RC; Drake AJ; Daly PL; Shakir KM
Thyroid; 2005 Feb; 15(2):170-5. PubMed ID: 15753678
[TBL] [Abstract][Full Text] [Related]
32. Empiric high-dose 131-iodine therapy lacks efficacy for treated papillary thyroid cancer patients with detectable serum thyroglobulin, but negative cervical sonography and 18F-fluorodeoxyglucose positron emission tomography scan.
Kim WG; Ryu JS; Kim EY; Lee JH; Baek JH; Yoon JH; Hong SJ; Kim ES; Kim TY; Kim WB; Shong YK
J Clin Endocrinol Metab; 2010 Mar; 95(3):1169-73. PubMed ID: 20080852
[TBL] [Abstract][Full Text] [Related]
33. Iodine-123 uptake in vertebral haemangiomas in a patient with papillary thyroid carcinoma.
Khan S; Dunn J; Strickland N; Al-Nahhas A
Nucl Med Rev Cent East Eur; 2008; 11(1):30-3. PubMed ID: 19173186
[TBL] [Abstract][Full Text] [Related]
34. Pitfalls of I-131 whole body scan interpretation: bronchogenic cyst and mucinous cystadenoma.
Agriantonis DJ; Hall L; Wilson MA
Clin Nucl Med; 2008 May; 33(5):325-7. PubMed ID: 18431144
[TBL] [Abstract][Full Text] [Related]
35. An unusual case of a false-positive iodine-131 whole body scan in a patient with papillary thyroid cancer.
Ceccarelli C; Pacini F; Lippi F; Pinchera A
Clin Nucl Med; 1988 Mar; 13(3):192-3. PubMed ID: 3289821
[TBL] [Abstract][Full Text] [Related]
36. Clinical value of different responses of serum thyroglobulin to recombinant human thyrotropin in the follow-up of patients with differentiated thyroid carcinoma.
David A; Blotta A; Rossi R; Zatelli MC; Bondanelli M; Roti E; Braverman LE; Busutti L; degli Uberti EC
Thyroid; 2005 Feb; 15(2):158-64. PubMed ID: 15753676
[TBL] [Abstract][Full Text] [Related]
37. Clinical relevance of single-photon emission computed tomography/computed tomography of the neck and thorax in postablation (131)I scintigraphy for thyroid cancer.
Aide N; Heutte N; Rame JP; Rousseau E; Loiseau C; Henry-Amar M; Bardet S
J Clin Endocrinol Metab; 2009 Jun; 94(6):2075-84. PubMed ID: 19276233
[TBL] [Abstract][Full Text] [Related]
38. Combined [18F]Fluorodeoxyglucose positron emission tomography and computed tomography (FDG-PET/CT) for detection of recurrent, 131I-negative thyroid cancer.
Finkelstein SE; Grigsby PW; Siegel BA; Dehdashti F; Moley JF; Hall BL
Ann Surg Oncol; 2008 Jan; 15(1):286-92. PubMed ID: 17882493
[TBL] [Abstract][Full Text] [Related]
39. Artifacts, anatomical and physiological variants, and unrelated diseases that might cause false-positive whole-body 131-I scans in patients with thyroid cancer.
Shapiro B; Rufini V; Jarwan A; Geatti O; Kearfott KJ; Fig LM; Kirkwood ID; Gross MD
Semin Nucl Med; 2000 Apr; 30(2):115-32. PubMed ID: 10787192
[TBL] [Abstract][Full Text] [Related]
40. Postradioiodine treatment whole-body scan in the era of 18-fluorodeoxyglucose positron emission tomography for differentiated thyroid carcinoma with elevated serum thyroglobulin levels.
Leboulleux S; El Bez I; Borget I; Elleuch M; Déandreis D; Al Ghuzlan A; Chougnet C; Bidault F; Mirghani H; Lumbroso J; Hartl D; Baudin E; Schlumberger M
Thyroid; 2012 Aug; 22(8):832-8. PubMed ID: 22853728
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
